Patent · US Active

Peanut formulations and uses thereof

US10086068B2 · kind B2 · utility

13Cited by
3References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2016
Grant dateOct 2, 2018
Priority date
Expiry dateOct 14, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.